Patients with CLL who spontaneously regress despite harboring TP53 mutations in their CLL clone provide further testament to the notion that the mere presence of CLL genetic drivers is insufficient to drive clonal evolution or disease progression (7). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.